BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29313448)

  • 1. Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.
    Chen MM; Harris JP; Orosco RK; Sirjani D; Hara W; Divi V
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1051-1056. PubMed ID: 29313448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.
    George JR; Yom SS; Wang SJ
    Laryngoscope; 2014 Jul; 124(7):1603-8. PubMed ID: 24318221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.
    Tam S; Araslanova R; Low TH; Warner A; Yoo J; Fung K; MacNeil SD; Palma DA; Nichols AC
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):685-690. PubMed ID: 28448645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion.
    Rubin SJ; Gurary EB; Qureshi MM; Salama AR; Ezzat WH; Jalisi S; Truong MT
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):77-84. PubMed ID: 29944460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
    Chinn SB; Spector ME; Bellile EL; Rozek LS; Lin T; Teknos TN; Prince ME; Bradford CR; Urba SG; Carey TE; Eisbruch A; Wolf GT; Worden FP; Chepeha DB
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):134-42. PubMed ID: 24370563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study.
    Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Kreppel M; Zöller J; Fridman E; Bolzoni VA; Shah JP; Binenbaum Y; Patel SG; Gil Z;
    Cancer; 2013 Dec; 119(24):4242-8. PubMed ID: 24114787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the clinical outcomes of initial surgery and primary definitive radiotherapy with a dosage of 6600 cGy or higher in cT1-2N0M0 oral cavity squamous cell carcinoma: A nationwide cohort study.
    Lin CY; Chen WC; Wen YW; Fan KH; Lin JC; Ng SH; Tsai YT; Lee SR; Kang CJ; Lee LY; Chien CY; Hua CH; Wang CP; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2024 May; 13(10):e7127. PubMed ID: 38770540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinoma.
    Lin CY; Lee LY; Cheng NM; Lee SR; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
    Cancer Med; 2021 Oct; 10(20):6947-6958. PubMed ID: 34558224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
    Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
    BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depth of invasion alone as a prognostic factor in low-risk early-stage oral cavity carcinoma.
    Kozak MM; Shah J; Chen M; Schaberg K; von Eyben R; Chen JJ; Bui T; Kong C; Kaplan M; Divi V; Hara W
    Laryngoscope; 2019 Sep; 129(9):2082-2086. PubMed ID: 30604435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base.
    Luryi AL; Chen MM; Mehra S; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):593-8. PubMed ID: 25974757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Compliance With Process-Related Quality Metrics and Improved Survival in Oral Cavity Squamous Cell Carcinoma.
    Graboyes EM; Gross J; Kallogjeri D; Piccirillo JF; Al-Gilani M; Stadler ME; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):430-7. PubMed ID: 26869135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adjuvant treatment in early-stage oral cavity squamous cell carcinoma: An international collaborative study.
    Fridman E; Na'ara S; Agarwal J; Amit M; Bachar G; Villaret AB; Brandao J; Cernea CR; Chaturvedi P; Clark J; Ebrahimi A; Fliss DM; Jonnalagadda S; Kohler HF; Kowalski LP; Kreppel M; Liao CT; Patel SG; Patel RS; Robbins KT; Shah JP; Shpitzer T; Yen TC; Zöller JE; Gil Z;
    Cancer; 2018 Jul; 124(14):2948-2955. PubMed ID: 29757457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
    Sklenicka S; Gardiner S; Dierks EJ; Potter BE; Bell RB
    J Oral Maxillofac Surg; 2010 Jun; 68(6):1270-5. PubMed ID: 20347201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of positive margin on survival in oral cavity squamous cell carcinoma.
    Patel V; Galloway TJ; Liu JC
    Oral Oncol; 2021 Nov; 122():105499. PubMed ID: 34509101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database.
    Torrecillas V; Shepherd HM; Francis S; Buchmann LO; Monroe MM; Lloyd S; Cannon D; Hitchcock YJ; Weis JR; Hunt JP; Houlton JJ; Cannon RB
    Oral Oncol; 2018 Oct; 85():1-7. PubMed ID: 30220313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
    Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
    Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
    Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
    Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.